Dmitri Kireev
Professor of the Chemistry Department at the College of Arts and Science, University of Missouri
Prof. Kireev’s broad expertise is in computational biophysics, drug discovery and life sciences with a specific focus on computer-aided drug design. He gained his expertise in computational drug discovery when working at Sanofi, a pharmaceutical world major company, where Prof. Kireev most recently served as Head of Drug Design in Montpellier (France) and contributed to the development of several drug candidates. In 2008, he joined University of North Carolina at Chapel Hill where his group was involved in 50+ translational projects and collaborations. Also at UNC, Prof. Kireev co-invented an anticancer drug, MRX-2843, which entered clinical trials in 2018. His research program also includes computational biophysics and development of new CADD approaches and overall resulted in more than 100 patents and publications.
